Description: Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.
Home Page: www.dawnrays.com
CNT Tower
Wan Chai,
Hong Kong
Phone:
852 2111 9708
Officers
| Name | Title |
|---|---|
| Ms. Kei Ling Li | Co-Founder & Exec. Chairman |
| Mr. Yung Lai Hung | Co-Founder & Exec. Director |
| Mr. Weixian Wu | Chief Exec. Officer |
| Mr. Yi Jun Wu | Chief Financial Officer |
| Ms. Kit Ling Pang | Company Sec. |
Exchange: HK
Country: HK
Currency: Hong Kong Dollar (HK$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 4.6071 |
| Price-to-Book MRQ: | 0.7052 |
| Price-to-Sales TTM: | 1.7018 |
| IPO Date: | 2003-07-11 |
| Fiscal Year End: | December |
| Full Time Employees: | 1058 |